Figure 6
From: CYLD regulates keratinocyte differentiation and skin cancer progression in humans
Immunocharacterization of A-control, A-CYLDWT and A-CYLDC/S tumors. Staining with specific antibodies against CYLD, K10, K8 and K5. The increased K8 expression in the A-CYLDC/S tumors, together with lack of K5 and K10 staining are indicative of an aggressive phenotype. Tumors (10–12) of each type were analyzed
